Market Cap

Cocrystal Pharma, Inc. Market Capitalization:

$18.5 Million

USD as of Jan. 1, 2024

business Cocrystal Pharma, Inc. Company Profile

Cocrystal Pharma, Inc. Main Stock Listing

NASDAQ: COCP

Market Capitalization History of Cocrystal Pharma, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Cocrystal Pharma, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $18.5 M -3.91%
Jan. 1, 2023 $19.2 M 310.71%
Jan. 1, 2022 $4.7 M -67.44%
Jan. 1, 2021 $14.4 M 173.02%
Jan. 1, 2020 $5.3 M -78.28%
Jan. 1, 2019 $24.2 M -31.12%
Jan. 1, 2018 $35.2 M -64.02%
Jan. 1, 2017 $97.8 M -36.07%
Jan. 1, 2016 $152.9 M 35.56%
Jan. 1, 2015 $112.8 M -21.05%
Jan. 1, 2014 $142.9 M -84.80%
Jan. 1, 2013 $940.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Cocrystal Pharma, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Cocrystal Pharma, Inc. has the following listings and related stock indices.


Stock: NASDAQ: COCP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.